FountainVest, Primavera invest $557m in China pharmacy chain
FountainVest Partners and Primavera Capital have paid $557 million for a 24.78% stake in Chinese pharmacy chain Laobaixing. It will provide a full exit for EQT Partners.
The two investors will each take approximately 12.4% shares via FountainVest China Capital Partners Fund III and Primavera Capital Fund III, according to a statement. EQT Partners became the second-largest...
More on Greater China
Latest News
CITIC Capital targets OBOR deals with blank check company
CITIC Capital has launched a special purpose acquisition vehicle (SPAC) – or blank check company – on the New York Stock Exchange to pursue deals under its One Belt One Road (OBOR) strategy.
AVCJ Awards 2019: Fundraising of the Year - Venture Capital: A91 Partners
A91 Partners’ spinout from Sequoia Capital showcases the deepening networks of the Indian VC space and hints that more ecosystem growth is yet to come
Northstar seeks $800m for Southeast Asia fund
Northstar Group, a Southeast Asia-focused private equity firm that counts Indonesia as its core market, is looking to raise $800 million for its fifth fund, according to sources familiar with the situation.
Fund focus: Baring sees stability in scale
Jean Eric Salata, CEO of Baring Private Equity Asia, argues that a $6.5 billion fund is not too large for Asia – he wishes he’d raised more – and explains why size increasingly represents a competitive advantage